Scott D Lane
Overview
Explore the profile of Scott D Lane including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
144
Citations
2147
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Machado-Vieira R, Krause T, Jones G, Teixeira A, Shahani L, Lane S, et al.
PLoS One
. 2025 Feb;
20(2):e0310438.
PMID: 39992948
The coronavirus disease pandemic caused by the coronavirus SARS-CoV-2, which emerged in the United States in late 2019 to early 2020 and quickly escalated into a national public health crisis....
2.
Hull K, Bing-Canar H, Miloslavich K, Holden C, Ahluwalia A, Lane S, et al.
Subst Use Misuse
. 2025 Feb;
:1-7.
PMID: 39967049
Background: Posttraumatic stress disorder (PTSD) symptoms are common in people with cocaine use disorder (CUD), and even sub-threshold PSTD symptoms result in worse treatment outcomes. Difficulties with reward functioning may...
3.
de Dios C, Suchting R, Green C, Webber H, Moeller F, Lane S, et al.
Am J Drug Alcohol Abuse
. 2025 Jan;
51(1):73-84.
PMID: 39853194
Cocaine use disorder (CUD) is associated with executive functioning impairments linked to serotonergic function. Previous studies reported efficacy with the selective serotonin reuptake inhibitor citalopram in reducing cocaine use. The...
4.
Webber H, Badawi J, Schmitz J, Yoon J, Calvillo D, Becker C, et al.
J Sleep Res
. 2024 Sep;
:e14330.
PMID: 39238202
People who use substances commonly experience sleep disruptions, affecting the regulation of physical and mental health, and presenting a significant barrier to treatment success. Sleep impairments are noted in all...
5.
Machado-Vieira R, Jones G, Courtes A, Ruiz A, Vecera C, Henter I, et al.
J Affect Disord
. 2024 Aug;
367:281-285.
PMID: 39214377
Background: Fatigue is a multidimensional condition that may overlap with depression. Initial studies found that fatigue responds in only a limited way to standard monoaminergic antidepressants and mood stabilizers but...
6.
Nunez C, Yoon J, de Dios C, Dang V, Lane S, Vincent J, et al.
Exp Clin Psychopharmacol
. 2024 Aug;
33(1):91-99.
PMID: 39207396
Cocaine use disorder (CUD) is a major public health issue, and greater cocaine use severity has been associated with worse treatment retention and outcomes. Therefore, greater understanding of processes that...
7.
Wardle M, Webber H, Yoon J, Heads A, Stotts A, Lane S, et al.
Pharmacol Biochem Behav
. 2024 May;
240():173787.
PMID: 38705285
Behavioral therapies are considered best practices in the treatment of substance use disorders (SUD) and used as first-line approaches for SUDs without FDA-approved pharmacotherapies. Decades of research on the neuroscience...
8.
Jones G, Vecera C, Ruiz A, Wu H, McInturff S, Orejarena M, et al.
J Clin Psychiatry
. 2024 May;
85(2).
PMID: 38696221
Although individuals with a family history of alcohol use disorder (AUD) have a superior antidepressant response to ketamine, outcomes in patients with current AUD remain unclear. This study sought to...
9.
Kessler D, Webber H, de Dios C, Yoon J, Schmitz J, Lane S, et al.
J Health Psychol
. 2024 Apr;
29(7):680-689.
PMID: 38641873
Prescribed opioids are a mainstay pain treatment after traumatic injury, but a subgroup of patients may be at risk for continued opioid use. We evaluated the predictive utility of a...
10.
Schmitz J, Stotts A, Vujanovic A, Yoon J, Webber H, Lane S, et al.
Drug Alcohol Depend
. 2024 Feb;
256:111078.
PMID: 38309089
Background: This study tested an adaptive intervention for optimizing abstinence outcomes over phases of treatment for cocaine use disorder using a SMART design. Phase 1 assessed whether 4 weeks of...